These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 30177597)
1. Safety and Efficacy of PrabotulinumtoxinA (Nabota Kim DY; Kim JM Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30177597 [TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design. Nicol AL; Wu II; Ferrante FM Anesth Analg; 2014 Jun; 118(6):1326-35. PubMed ID: 24842179 [TBL] [Abstract][Full Text] [Related]
3. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study. Seo HG; Bang MS; Chung SG; Jung SH; Lee SU Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438 [TBL] [Abstract][Full Text] [Related]
4. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial. Ojala T; Arokoski JP; Partanen J Clin J Pain; 2006 Jan; 22(1):90-6. PubMed ID: 16340597 [TBL] [Abstract][Full Text] [Related]
5. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections? Benecke R; Heinze A; Reichel G; Hefter H; Göbel H; Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970 [TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Wheeler AH; Goolkasian P; Gretz SS Spine (Phila Pa 1976); 1998 Aug; 23(15):1662-6; discussion 1667. PubMed ID: 9704373 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study. Göbel H; Heinze A; Reichel G; Hefter H; Benecke R; Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294 [TBL] [Abstract][Full Text] [Related]
8. Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type A. Ferrante FM; Bearn L; Rothrock R; King L Anesthesiology; 2005 Aug; 103(2):377-83. PubMed ID: 16052120 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study. Kwanchuay P; Petchnumsin T; Yiemsiri P; Pasuk N; Srikanok W; Hathaiareerug C J Med Assoc Thai; 2015 Dec; 98(12):1231-6. PubMed ID: 27004309 [TBL] [Abstract][Full Text] [Related]
10. A critical appraisal of the evidence for botulinum toxin type A in the treatment for cervico-thoracic myofascial pain syndrome. Desai MJ; Shkolnikova T; Nava A; Inwald D Pain Pract; 2014 Feb; 14(2):185-95. PubMed ID: 23692187 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin for myofascial pain syndromes in adults. Soares A; Andriolo RB; Atallah AN; da Silva EM Cochrane Database Syst Rev; 2012 Apr; (4):CD007533. PubMed ID: 22513950 [TBL] [Abstract][Full Text] [Related]
12. The analgesic effect of botulinum-toxin A on postwhiplash neck pain. Braker C; Yariv S; Adler R; Badarny S; Eisenberg E Clin J Pain; 2008 Jan; 24(1):5-10. PubMed ID: 18180629 [TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review. Ho KY; Tan KH Eur J Pain; 2007 Jul; 11(5):519-27. PubMed ID: 17071119 [TBL] [Abstract][Full Text] [Related]
14. An update on botulinum toxin A injections of trigger points for myofascial pain. Zhou JY; Wang D Curr Pain Headache Rep; 2014 Jan; 18(1):386. PubMed ID: 24338700 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study. Lew HL; Lee EH; Castaneda A; Klima R; Date E Arch Phys Med Rehabil; 2008 Jan; 89(1):75-80. PubMed ID: 18164334 [TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A trigger point injections for myofascial pelvic pain. Dessie SG; Von Bargen E; Hacker MR; Haviland MJ; Elkadry E Am J Obstet Gynecol; 2019 Nov; 221(5):517.e1-517.e9. PubMed ID: 31254522 [TBL] [Abstract][Full Text] [Related]
17. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans. De Andrés J; Adsuara VM; Palmisani S; Villanueva V; López-Alarcón MD Reg Anesth Pain Med; 2010; 35(3):255-60. PubMed ID: 20921836 [TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin for myofascial pain syndromes in adults. Soares A; Andriolo RB; Atallah AN; da Silva EM Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD007533. PubMed ID: 25062018 [TBL] [Abstract][Full Text] [Related]
19. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Porta M Pain; 2000 Mar; 85(1-2):101-5. PubMed ID: 10692608 [TBL] [Abstract][Full Text] [Related]
20. Injection in the cervical facet joint for shoulder pain with myofascial trigger points in the upper trapezius muscle. Tsai CT; Hsieh LF; Kuan TS; Kao MJ; Hong CZ Orthopedics; 2009 Aug; 32(8):. PubMed ID: 19708635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]